DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ shed 3.06% to $10.30 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.59% to 24,259.96 and Dow Jones Industrial Average falling 0.59% to 49,149.38.
The stock's fall snapped a three-day winning streak.
Corbus Pharmaceuticals Holdings Inc. closed 49.93% short of its 52-week high of $20.56, which the company achieved on October 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 3.00% to $6.78, Fortress Biotech Inc. (FBIO) fell 3.88% to $2.23, and Viking Therapeutics Inc. (VKTX) fell 4.87% to $33.80.
Trading volume (185,569) remained 28,109 below its 50-day average volume of 213,678.
Data source: Dow Jones Market Data, FactSet. Data compiled April 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 21, 2026 17:20 ET (21:20 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments